Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Liver crawled date : 2021 - 06 - 22 save search
PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech
Published: 2021-06-22 (Crawled : 13:00) - biospace.com/
PKI | $115.24 0.0% 1.6M
|
Health Technology
|
| O: 0.39%
H: 1.69%
C: 0.12%
biotech iot liver
3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments
Published: 2021-06-22 (Crawled : 13:00) - globenewswire.com
DDD F | $3.39 -2.59% 1.77% 1.3M
|
Producer Manufacturing
|
| O: 2.49%
H: 30.24%
C: 24.56%
CLGN | $5.24 1.52% 1.5% 6.7K
|
Health Technology
|
| O: -0.55%
H: 21.07%
C: 13.24%
treatment liver
Iridium Certus® 200: Delivering an Unmatched Performance/Value Equation for Satellite Broadband Services
Published: 2021-06-22 (Crawled : 12:15) - prnewswire.com
IRDM | $24.71 -0.28% -0.28% 1.4M
|
Communications
|
| O: 0.0%
H: 0.82%
C: 0.49%
satellite liver
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-06-22 (Crawled : 12:15) - biospace.com/
NVO | News | $124.53 0.88% 0.19% 2.5M
|
Health Technology
|
| O: -0.39%
H: 0.27%
C: -0.21%
LLY | News | $750.77 0.54% 0.22% 2.8M
|
Health Technology
|
| O: -0.02%
H: 0.44%
C: -0.53%
ALNY | $145.32 -0.95% -1.03% 260K
|
Health Technology
|
| O: 0.08%
H: 1.01%
C: 0.9%
disease liver disease treatment phase 2 liver trial
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of "ultra-long-acting" medicines for HIV
Published: 2021-06-22 (Crawled : 07:00) - prnewswire.com
PFE A | $25.42 -1.05% 0.16% 40M
|
Health Technology
|
| O: -0.03%
H: 0.71%
C: 0.51%
GSK | $39.6 -0.88% 0.03% 2.6M
|
Health Technology
|
| O: -0.7%
H: 0.05%
C: -1.06%
HALO M | $38.02 -0.94% -0.95% 730K
|
Health Technology
|
| O: 0.19%
H: 2.15%
C: 1.89%
collaboration drug license technology drug delivery liver hiv
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.